Antidepressant Maker Seaport Raises $255 Million in Upsized IPO
✨ AI Summary
🔊 جاري الاستماع
Seaport Therapeutics Inc., a clinical-stage biotechnology company focused on antidepressants and anxiety drugs, raised nearly $255 million in an upsized US initial public offering that priced at the top of its marketed range.
